News About: Pharm. Industry
Novartis Korea assigned Zelmac promotion to Uthis.
Novartis Korea announced to assign a product detailing activity of Zelmac (tegacerod) sales promotion in local private clinic markets under a certain agreement with Uthis company, a specialized out-sourcing company in...
New drug pricing policy should be go into effect gradually
Korea's drug pricing and reimbursement policies need to take effect by phase after health authorities will have a sufficient number of experts who are able to evaluate the pharmacoeconomics, according to a local profe...
Mandates for small drug packages should be supplemented.
The production or supply of small packaged drugs was provisionally mandated to the drug company on Oct. 7, 2006 but in its implementing process they found a lot of problems in connection with the inventory pile-up and...
Janssen Korea President takes aims Korea's top drug maker
Choi Tae-hong, president of Janssen Korea, said he will aggressively revamp the company's human resources in order to make the company one of Korea's leading pharmaceutical companies in terms of revenue, profit and sh...
Industry hardly finds OTC marketing experts.
Local drug companies are trying to activate the OTC drug business but encountered with difficulties in finding a OTC drug marketing expert.
Most of local pharmaceutical companies adopted aggressive strategies this ...
Drug wholesalers eye MR certification system
The Korean Association of Pharmaceutical Wholesaler plans to introduce a marketing representative (MR) system as part of its efforts to ensure better detailing capacity of sales personnel and nurture able medical repr...
Domestic pharmaceutical firms urged to explore overseas market with better license procedures
Korean drugmakers need to successfully explore foreign markets with their thorough strategies via better understanding of foreign countries' registration requirements, globalization of promising items, and establishme...
Wholesalers face shortage of Lamisil cream
Wholesalers has been suffering from a shortage of Lamisil cream, co-marketed by Novartis Korea and Pacific Pharm, since its inventories were wholly returned to the manufacturer due to reduction of insurance price.
...
R&D strategies of major domestic drugmakers outlined
Although local pharmaceutical companies have been developing a variety of generic drugs as patients want cheaper medications, the majority of the companies will become more eager to sell name-brand medicines for highe...
Smaller packets headache for wholesalers
Wholesalers have found it increasingly difficult to deal with medicines in smaller units.
Pharmacists are also demanding wholesalers sell medicines in smaller units containing 30 tablets instead of a large canister...
